If you work with clients who use ventilators —especially ventilators carried by their power wheelchairs and connected to those batteries — take note. Philips Respironics has significantly reduced its respiratory and sleep portfolio of products for the United States.
In a Jan. 25 announcement, the manufacturer listed products it was discontinuing. The list of products discontinued on Jan. 25 included the Trilogy EVO and EV300 home ventilators. Philips Respironics will continue to service discontinued products until their end-of-service dates — Jan. 25, 2029, for the Trilogy EVO and EV300 ventilators.
Philips Respironics said it “will not return to the sale of hospital ventilation products, certain home ventilation products, portable and stationary oxygen concentrators and sleep diagnostic products.”
On Jan. 29, Philips announced it had reached a consent decree with the U.S. Department of Justice and U.S. Food & Drug Administration. As a result, the company will not sell new CPAP, BiPAP, or respiratory care devices in the United States until consent decree requirements are met.
